Abstract
AbstractThe chicken embryo hepatocyte‐7‐ethoxyresorufin O‐deethylase (EROD) assay is used as a method to measure the amount of 2,3,7,8‐tetrachlorodibenzo‐p‐dioxin (2,3,7,8‐TCDD) equivalents (TEQs) in environmental samples. A common feature of EROD‐induction assays in vertebrates is that they generate biphasic dose‐response relationships that show dose‐related increases of the EROD induction to a maximum activity, followed by a dose‐related decrease at higher concentrations. In general, the maximum achievable enzyme activity decreases with increasing median effective concentration (EC50). This suggests that aryl hydrocarbon (Ah)‐receptor binding affinity is not the only factor determining the enzyme activity. An additional factor can obscure the maximum EROD activity (Ymax) and EC50 of the enzyme activity. Cytotoxicity and competitive inhibition are ruled out as possible influencing factors. Coadministration of 2, 2′, 4, 4′, 5, 5′‐hexachlorobiphenyl (PCB 153) and 2, 3, 7, 8‐TCDD significantly reduces the EC50 value compared to administration of TCDD alone. The dose‐related decrease at higher concentrations has been suggested to be induced by mechanisms other than the Ah‐receptor‐related mechanism responsible for the observed increases at low concentrations. These interactive effects have serious consequences for risk assessment based on bioassay‐derived TEQs.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
